Skip to content
Screener

Omnicell OMCL Common stock, par value (in dollars per share)

Common stock, par value (in dollars per share) at other companies

ICU Medical logo
ICU MedicalICUI
$0.10.0%
Nutex Health Inc. logo
Nutex Health Inc.NUTX
$00.0%
Solventum logo
SolventumSOLV
$0.010.0%
Baxter International logo
Baxter InternationalBAX
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
InfuSystem Holdings logo
InfuSystem HoldingsINFU

Other financials

Income statement

See full
Revenue$312.2M+7.4%
Gross profit$152.9M+19.8%
Operating income$32.4M+300%
Net income$24.3M+331%
EPS (diluted)$0.52+333%

Balance sheet

See full
Cash & equivalents$322.8M-25.2%
Total debt$31.8M-25.4%
Total equity$1.3B+2.2%
Total assets$2.0B-6.8%

Cash flow

See full
Operating cash flow$68.3M+59.8%
CapEx$8.9M-24.1%
Free cash flow$59.4M+91.7%

Valuation

See full
Market cap$1.68B+18.6%
Enterprise value$1.39B+35.1%
P/E35.9×
P/S1.4×+0.1×

Profitability

See full
Gross margin44.8%+1.0pp
Operating margin4.6%+3.3pp
Net margin1.7%+1.1pp
FCF margin11.4%+2.1pp

Returns & leverage

See full
Return on equity1.6%+1.1pp
Debt / equity0.0×
Current ratio1.6×+0.2×

Where this comes from

Reported directly by Omnicell in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The source filing: Omnicell’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000926326-26-000022
Line itemJune 30,2026December 31,2025
Commitments and contingencies (Note 14)
Stockholders’ equity:
Preferred stock, $0.001 par value, 5,000 shares authorized; no shares issued
Common stock, $0.001 par value, 100,000 shares authorized; 58,419 and 57,833 shares issued; 45,613 and 45,027 shares outstanding, respectively5858
Treasury stock at cost, 12,806 shares outstanding(368,307)(368,307)
Additional paid-in capital1,250,3821,223,977
Retained earnings420,587384,940
Accumulated other comprehensive loss(11,115)(8,854)

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is Omnicell's common stock, par value (in dollars per share)?
Omnicell (OMCL) reported common stock, par value (in dollars per share) of $0 in Q2 2026.
How has Omnicell's common stock, par value (in dollars per share) changed year-over-year?
Omnicell's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
What is the long-term trend for Omnicell's common stock, par value (in dollars per share)?
Over 5 years (2020 to 2025), Omnicell's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.
What does common stock, par value (in dollars per share) mean?
Common stock, par value (in dollars per share)

Ask your AI about Omnicell's common stock, par value (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude